BNP Paribas Exane Issues Positive Forecast for Corteva (NYSE:CTVA) Stock Price

Corteva (NYSE:CTVA) had its price target upped by BNP Paribas Exane from $74.00 to $77.00 in a research report report published on Wednesday,MarketScreener reports.

A number of other equities analysts have also recently weighed in on CTVA. Argus lifted their price target on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Tuesday, March 31st. Wall Street Zen cut Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Rothschild & Co Redburn lifted their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. UBS Group lifted their price target on Corteva from $80.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, April 9th. Finally, Royal Bank Of Canada lifted their price target on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research note on Friday, April 24th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $86.62.

Corteva Price Performance

NYSE:CTVA traded down $2.33 during mid-day trading on Wednesday, reaching $79.45. 636,583 shares of the stock were exchanged, compared to its average volume of 3,957,653. The business has a fifty day moving average price of $80.66 and a 200 day moving average price of $72.48. The firm has a market capitalization of $53.34 billion, a PE ratio of 46.70, a PEG ratio of 2.88 and a beta of 0.59. Corteva has a 1-year low of $60.53 and a 1-year high of $85.63. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.88% and a net margin of 6.50%.Corteva’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the business posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts expect that Corteva will post 3.62 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is 45.57%.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.15% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares during the last quarter. State Street Corp lifted its holdings in shares of Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after buying an additional 1,290,071 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after buying an additional 805,873 shares during the last quarter. Harris Associates L P increased its position in shares of Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the period. Finally, Northern Trust Corp increased its position in shares of Corteva by 5.0% during the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after purchasing an additional 562,550 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.